pre-miRNA Information | |
---|---|
pre-miRNA | hsa-mir-1299 |
Genomic Coordinates | chr9: 40929010 - 40929092 |
Synonyms | MIRN1299, hsa-mir-1299, MIR1299 |
Description | Homo sapiens miR-1299 stem-loop |
Comment | None |
RNA Secondary Structure | |
Associated Diseases |
Mature miRNA Information | |||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Mature miRNA | hsa-miR-1299 | ||||||||||||||||||
Sequence | 62| UUCUGGAAUUCUGUGUGAGGGA |83 | ||||||||||||||||||
Evidence | Experimental | ||||||||||||||||||
Experiments | Illumina | ||||||||||||||||||
SNPs in miRNA |
|
||||||||||||||||||
Putative Targets |
miRNA Expression profile | |
---|---|
Human miRNA Tissue Atlas | |
miRNAs in Extracellular Vesicles |
|
Circulating MicroRNA Expression Profiling |
Gene Information | |||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Gene Symbol | STEAP3 | ||||||||||||||||||||
Synonyms | AHMIO2, STMP3, TSAP6, dudlin-2, dudulin-2, pHyde | ||||||||||||||||||||
Description | STEAP3 metalloreductase | ||||||||||||||||||||
Transcript | NM_001008410 | ||||||||||||||||||||
Other Transcripts | NM_018234 , NM_182915 | ||||||||||||||||||||
Expression | |||||||||||||||||||||
Putative miRNA Targets on STEAP3 | |||||||||||||||||||||
3'UTR of STEAP3 (miRNA target sites are highlighted) |
>STEAP3|NM_001008410|3'UTR 1 GGTGCCTGCCCTGGGCTCTGGACCCCGGGCACACGAGGGACGGTGCCCTGAGCCCGTTAGGTTTTCTTTTCTTGGTGGTG 81 CAAAGTGGTATAACTGTGTGCAAATAGGAGGTTTGAGGTCCAAATTCCTGGGACTCAAATGTATGCAGTACTATTCAGAA 161 TGATATACACACATATGTGTATATGTATTTACATATATTCCACATATATAACAGGATTTGCAATTATACATAGCTAGCTA 241 AAAAGTTGGGTCTCTGAGATTTCAACTTGTAGATTTAAAAACAAGTGCCGTACGTTAAGAGAAGAGCAGATCATGCTATT 321 GTGACATTTGCAGAGATATACACACACTTTTTGTACAGAAGAGGCTTGTGCTGTGGTGGGTTCGATTTATCCCTGCCCAC 401 CCCACCCCCACAACTTCCCTTTTGCTACTTCCCCAAGGCTCTTGCAGAGCTAGGGCTCTGAAGGGGAGGGAAGGCAACGG 481 CTCTGCCCAGAGCCATCCCTGGAGCATGTGAGCAGCGGCTGGTCTCTTCCCTCCACCTGGGGCAGCAGCAGGAGGCCTGG 561 GGAGGAGGAAAATCAGGCAGTCGGCCTGGAGTCTGTGCCTGGTCCTTTGCCCGGTGGTGGGAGGATGGAGGGATTGGGCT 641 GAAGCTGCTCCACCTCATCCTTGCTGAGTGGGGGAGACATTTTCCCTGAAAGTCAGAAGTCACCATAGAGCCTGCAAATG 721 GATCCTCCTGTGAGAGTGACGTCACCTCCTTTCCAGAGCCATTAGTGAGCCTGGCTTGGGAACAAGTGTAATTTCCTTCC 801 CTCCTTTAACCTGGCGATGAGCGTCCTTTAAACCACTGTGCCTTCTCACCCTTTCCATCTTCAGTTTGAATGACTCCCAG 881 GAAGGCCTAGAGCAGACCCTTTAGAAATCAGCCCAAGGGGGAGAGCAAGAGAAAACACTCTAGGGAGTAAAGCTCCCCGG 961 GCGTCAGAGTTGAGCCCTGCCTGGGCTGAAGGACTGTCTTCACGAAGTCAGTCCTGAGGAAAAATATTGGGGACTCCAAA 1041 TGTCCTCTGGCAGAGGACCCAGAAAACCACACTGGCTCCAACTTCCTCCTCATGGGGCATTACACTTCAAAACAGTGGGG 1121 AGCAACTTTTCCACCAAAGCTACAAACCTAAAATGCTGCTGCCCCAAAGCACAAGAGGGAAGAGCACCGCCGGGGCCACA 1201 GGACGTCTGTCCTCCAGTCACAGGCCATCCTTGCTGCTCCCTACTGACTCTAGCTTACTTCCCCTGTGAAGAAACAGGTG 1281 TTCTCGGCTGAGCCCCCAACCCTCTGCAGAACCAGGTTGATCTGCCACAGAAAAAGCATCTTTGAAGACAAAGAGGGTGA 1361 GGTCTTCATGAGTCTCCTGGGCCCAAAGCCATCTTCTGATGGAAGGAAGAGAGTAGGGCCAGTGAAGGCTGCCCAGAGAG 1441 AATGTCACAGATGAGGCTGCCCCTGCCCCCCCCCCGCCAGGGAGGTTTCATGAGCTCATGTCTATGCAGCACATAAGGGT 1521 TCTTCAGTGAAAAGCAGGAGAAGAGCCCACTGCAAGGATAGCTCATTAGGCACATGACCGATGCAGGGAAGGCCATGCCG 1601 GGGAAGCTCTTCCTGCAGGTATTTTCCATCTGCTGTGCCAAGGCTGAGCGGCAGAAACTTGTCTCATAAATTGGCACTGA 1681 TGGAGCATCAGCTGTGGCCCACAGAGAGCCTTGCTGAGAAGGGGGCAGGTAAAGCAGAGATTTTAGCATTGCCTTGGCAT 1761 AACAAGGGCCCATCGATTCCCTACTAATGAGAGGCAGGGAGAGCATGGGCAATGGAGACCCACCAATGATCCCCAACCCC 1841 GGTGGGTACTGGCTGCCTGCCCTGGGCCAGGGAATGGCTCCTTATACCAAAGATGCTGGCACATAGCAGAACCCAGTGCA 1921 CGTCCTCCCCTTCCCACCCACCTCTGGCTGAAGGTGCTCAAGAGGGAAGCAATTATAAGGTGGGTGGCAGGAGGGAACAG 2001 GTGCCACCTGCTGGACAATCACACGAAAGGCAGGCGGGCTGTGTACTGGGCCCTGACTGTGCGTCCACTGCTGTCTTCCC 2081 TACCTCACCAGGCTACTGGCAGCAGCATCCCGAGAGCACATCATCTCCACAGCCTGGTAAATTCCATGTGCCTCTGGGTA 2161 CAAAAGTGCCTCAACGACATGCTCTGGAAATCCCAAATGCCACAGTCTGAGGTTGATATCTAAAATCTATGCCTTCAAAA 2241 GAGTCTCTGTTTTTTTTTTTTAACCTGGTAGACAGTATAAAAGCAGTGCAAATAAACACCTAACCTTCTGCAAA Target sites
Provided by authors
Predicted by miRanda
DRVs
SNPs
DRVs & SNPs
|
||||||||||||||||||||
miRNA-target interactions (Predicted by miRanda) |
|
||||||||||||||||||||
DRVs in gene 3'UTRs | |||||||||||||||||||||
SNPs in gene 3'UTRs |
Experimental Support 1 for Functional miRNA-Target Interaction | |||||||
---|---|---|---|---|---|---|---|
miRNA:Target | ---- | ||||||
Validation Method |
|
||||||
Conditions | HEK293 | ||||||
Disease | 55240.0 | ||||||
Location of target site | 3'UTR | ||||||
Tools used in this research | TargetScan , miRTarCLIP , Piranha | ||||||
Original Description (Extracted from the article) |
...
"PAR-CLIP data was present in GSM1065668. RNA binding protein: AGO1. Condition:4-thiouridine
... - Memczak S; Jens M; Elefsinioti A; Torti F; et al., 2013, Nature. |
||||||
miRNA-target interactions (Provided by authors) |
|
||||||
Article |
- Memczak S; Jens M; Elefsinioti A; Torti F; et al. - Nature, 2013
Circular RNAs (circRNAs) in animals are an enigmatic class of RNA with unknown function. To explore circRNAs systematically, we sequenced and computationally analysed human, mouse and nematode RNA. We detected thousands of well-expressed, stable circRNAs, often showing tissue/developmental-stage-specific expression. Sequence analysis indicated important regulatory functions for circRNAs. We found that a human circRNA, antisense to the cerebellar degeneration-related protein 1 transcript (CDR1as), is densely bound by microRNA (miRNA) effector complexes and harbours 63 conserved binding sites for the ancient miRNA miR-7. Further analyses indicated that CDR1as functions to bind miR-7 in neuronal tissues. Human CDR1as expression in zebrafish impaired midbrain development, similar to knocking down miR-7, suggesting that CDR1as is a miRNA antagonist with a miRNA-binding capacity ten times higher than any other known transcript. Together, our data provide evidence that circRNAs form a large class of post-transcriptional regulators. Numerous circRNAs form by head-to-tail splicing of exons, suggesting previously unrecognized regulatory potential of coding sequences.
LinkOut: [PMID: 23446348]
|
CLIP-seq Support 1 for dataset GSM1065668 | |
---|---|
Method / RBP | PAR-CLIP / AGO1 |
Cell line / Condition | HEK293 / 4-thiouridine, ML_MM_7 |
Location of target site | ENST00000409811.1 | 3UTR | GUCACCUCCUUUCCAGAGCCAUU |
Tools used in this analysis | TargetScan, miRTarCLIP, and Piranha |
Article / Accession Series | PMID: 23446348 / GSE43573 |
CLIP-seq Viewer | Link |
MiRNA-Target Expression Profile | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
MiRNA-Target Expression Profile (TCGA) | |||||||
---|---|---|---|---|---|---|---|
|
75 hsa-miR-1299 Target Genes:
Functional analysis:
ID | Target | Description | Validation methods | |||||||||
Strong evidence | Less strong evidence | |||||||||||
MIRT079552 | VAMP3 | vesicle associated membrane protein 3 | 2 | 2 | ||||||||
MIRT154885 | GNAS | GNAS complex locus | 2 | 4 | ||||||||
MIRT275056 | SESN2 | sestrin 2 | 2 | 4 | ||||||||
MIRT303051 | B3GNT2 | UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 2 | 2 | 4 | ||||||||
MIRT319158 | CCDC71L | coiled-coil domain containing 71 like | 2 | 2 | ||||||||
MIRT339620 | TMPO | thymopoietin | 2 | 2 | ||||||||
MIRT441961 | BACE2 | beta-site APP-cleaving enzyme 2 | 2 | 2 | ||||||||
MIRT445113 | DCAF4 | DDB1 and CUL4 associated factor 4 | 2 | 2 | ||||||||
MIRT445290 | CD274 | CD274 molecule | 2 | 2 | ||||||||
MIRT446037 | HMCN1 | hemicentin 1 | 2 | 2 | ||||||||
MIRT446162 | C8A | complement C8 alpha chain | 2 | 2 | ||||||||
MIRT446175 | ZNF37A | zinc finger protein 37A | 2 | 4 | ||||||||
MIRT446414 | OCA2 | OCA2 melanosomal transmembrane protein | 2 | 2 | ||||||||
MIRT446884 | TRIM25 | tripartite motif containing 25 | 2 | 2 | ||||||||
MIRT449789 | C1orf109 | chromosome 1 open reading frame 109 | 2 | 2 | ||||||||
MIRT450026 | EHD3 | EH domain containing 3 | 2 | 2 | ||||||||
MIRT450367 | ADAMTS5 | ADAM metallopeptidase with thrombospondin type 1 motif 5 | 2 | 2 | ||||||||
MIRT479739 | CCND1 | cyclin D1 | 2 | 2 | ||||||||
MIRT484809 | ZNFX1 | zinc finger NFX1-type containing 1 | 2 | 2 | ||||||||
MIRT485892 | ZFP36 | ZFP36 ring finger protein | 2 | 2 | ||||||||
MIRT486036 | UBBP4 | ubiquitin B pseudogene 4 | 2 | 2 | ||||||||
MIRT488295 | DHCR24 | 24-dehydrocholesterol reductase | 2 | 2 | ||||||||
MIRT497377 | METTL8 | methyltransferase like 8 | 2 | 2 | ||||||||
MIRT508219 | ZNF850 | zinc finger protein 850 | 2 | 6 | ||||||||
MIRT510923 | PRRX1 | paired related homeobox 1 | 2 | 4 | ||||||||
MIRT512661 | STEAP3 | STEAP3 metalloreductase | 2 | 2 | ||||||||
MIRT520031 | YOD1 | YOD1 deubiquitinase | 2 | 6 | ||||||||
MIRT528490 | AGTR2 | angiotensin II receptor type 2 | 2 | 2 | ||||||||
MIRT530083 | PAGR1 | PAXIP1 associated glutamate rich protein 1 | 2 | 4 | ||||||||
MIRT531086 | CCDC140 | coiled-coil domain containing 140 | 2 | 2 | ||||||||
MIRT535363 | PEX5L | peroxisomal biogenesis factor 5 like | 2 | 2 | ||||||||
MIRT535595 | NUDT21 | nudix hydrolase 21 | 2 | 2 | ||||||||
MIRT538613 | CCT5 | chaperonin containing TCP1 subunit 5 | 2 | 4 | ||||||||
MIRT539002 | AVL9 | AVL9 cell migration associated | 2 | 2 | ||||||||
MIRT545918 | ZC3H4 | zinc finger CCCH-type containing 4 | 2 | 2 | ||||||||
MIRT548482 | EEF2 | eukaryotic translation elongation factor 2 | 2 | 2 | ||||||||
MIRT555088 | PURB | purine rich element binding protein B | 2 | 2 | ||||||||
MIRT561421 | TRIB3 | tribbles pseudokinase 3 | 2 | 2 | ||||||||
MIRT564965 | WTAP | WT1 associated protein | 2 | 2 | ||||||||
MIRT571686 | RPRD2 | regulation of nuclear pre-mRNA domain containing 2 | 2 | 2 | ||||||||
MIRT574656 | KLHL15 | kelch like family member 15 | 2 | 2 | ||||||||
MIRT610037 | CNOT6 | CCR4-NOT transcription complex subunit 6 | 2 | 6 | ||||||||
MIRT612436 | SMOC2 | SPARC related modular calcium binding 2 | 2 | 2 | ||||||||
MIRT614349 | LOH12CR1 | BLOC-1 related complex subunit 5 | 2 | 2 | ||||||||
MIRT615304 | CCDC158 | coiled-coil domain containing 158 | 2 | 2 | ||||||||
MIRT615771 | FSD2 | fibronectin type III and SPRY domain containing 2 | 2 | 2 | ||||||||
MIRT615889 | MT1A | metallothionein 1A | 2 | 2 | ||||||||
MIRT619147 | ZNF326 | zinc finger protein 326 | 2 | 2 | ||||||||
MIRT622042 | SSBP2 | single stranded DNA binding protein 2 | 2 | 2 | ||||||||
MIRT637385 | R3HDM2 | R3H domain containing 2 | 2 | 2 | ||||||||
MIRT640739 | EPB41 | erythrocyte membrane protein band 4.1 | 2 | 2 | ||||||||
MIRT644418 | PIGS | phosphatidylinositol glycan anchor biosynthesis class S | 2 | 2 | ||||||||
MIRT647638 | FAIM2 | Fas apoptotic inhibitory molecule 2 | 2 | 2 | ||||||||
MIRT654305 | RBMS3 | RNA binding motif single stranded interacting protein 3 | 2 | 2 | ||||||||
MIRT654367 | RBM23 | RNA binding motif protein 23 | 2 | 2 | ||||||||
MIRT655944 | NDST1 | N-deacetylase and N-sulfotransferase 1 | 2 | 2 | ||||||||
MIRT655990 | MYRF | myelin regulatory factor | 2 | 2 | ||||||||
MIRT659692 | CD226 | CD226 molecule | 2 | 2 | ||||||||
MIRT665868 | TIAF1 | TGFB1-induced anti-apoptotic factor 1 | 2 | 2 | ||||||||
MIRT667317 | MYO18A | myosin XVIIIA | 2 | 2 | ||||||||
MIRT684312 | GTF3C4 | general transcription factor IIIC subunit 4 | 2 | 2 | ||||||||
MIRT694138 | CYP27C1 | cytochrome P450 family 27 subfamily C member 1 | 2 | 2 | ||||||||
MIRT698529 | TFRC | transferrin receptor | 2 | 2 | ||||||||
MIRT698834 | SSR2 | signal sequence receptor subunit 2 | 2 | 2 | ||||||||
MIRT700657 | PPP1R11 | protein phosphatase 1 regulatory inhibitor subunit 11 | 2 | 2 | ||||||||
MIRT705377 | ATP1B3 | ATPase Na+/K+ transporting subunit beta 3 | 2 | 2 | ||||||||
MIRT707314 | TMEM184B | transmembrane protein 184B | 2 | 2 | ||||||||
MIRT709027 | KBTBD13 | kelch repeat and BTB domain containing 13 | 2 | 2 | ||||||||
MIRT716032 | TMPRSS4 | transmembrane protease, serine 4 | 2 | 2 | ||||||||
MIRT718228 | LCE1A | late cornified envelope 1A | 2 | 2 | ||||||||
MIRT718475 | TMEM151A | transmembrane protein 151A | 2 | 2 | ||||||||
MIRT722333 | BEND6 | BEN domain containing 6 | 2 | 2 | ||||||||
MIRT734096 | TUG1 | taurine up-regulated 1 (non-protein coding) | 3 | 0 | ||||||||
MIRT734099 | NOTCH3 | notch 3 | 3 | 0 | ||||||||
MIRT755871 | LIF | LIF, interleukin 6 family cytokine | 4 | 1 |
miRNA-Drug Associations | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
miRNA-Drug Resistance Associations | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|